SCHEMBL30017520

SCHEMBL30017520

COc1cc2ncnc(Nc3ccc(Oc4ccccc4C#N)cc3)c2cc1OCCCN1CCOCC1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 7/20 0.75
MAP2K1 Q02750 7/20 0.70
RAF1 P04049 2/20 0.70
MAPK3 P27361 1/20 0.70
MAPK1 P28482 1/20 0.70
KDR P35968 5/20 0.70
EGFR P00533 7/20 0.66
LCK P06239 2/20 0.66
RET P07949 2/20 0.66
MET P08581 2/20 0.66
MAPT P10636 2/20 0.66
LTK P29376 2/20 0.66
TNK2 Q07912 2/20 0.66
MAP4K5 Q9Y4K4 2/20 0.66
AURKA O14965 2/20 0.66
AURKB Q96GD4 2/20 0.66
ROCK2 O75116 1/20 0.66
ALDH1A1 P00352 1/20 0.66
FYN P06241 1/20 0.66
PDGFRA P16234 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13529060 0.86 SRC (0.84) SRCMAP2K1KDREGFRLCK
SCHEMBL800013 0.85 EGFR (0.78) SRCKDREGFRLCKRET
SCHEMBL28424819 0.84 SRC (0.85) SRCMAP2K1KDREGFRLCK
SCHEMBL3531151 0.83 SRC (0.86) SRCMAP2K1KDREGFRLCK
SCHEMBL346145 0.82 MAP2K1 (1.00) SRCMAP2K1RAF1MAPK3MAPK1
SCHEMBL30018005 0.82 EGFR (0.81) EGFR
SCHEMBL30016831 0.82 EGFR (0.60) SRCRAF1KDREGFRLCK
SCHEMBL4447752 0.81 MAP2K1 (0.86) SRCMAP2K1RAF1MAPK3MAPK1
SCHEMBL6704281 0.81 EGFR (0.80) SRCMAP2K1KDREGFRLCK
SCHEMBL6995929 0.81 MAP2K1 (0.85) SRCMAP2K1RAF1MAPK3MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115403557-A Quinoline and quinazoline compounds as fourth-generation EGFR (epidermal growth factor receptor) inhibitor and application thereof 华东理工大学 2022-11-29 CN disclosed